Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial.

Beal G, Barbier C, Thoret S, Rubio A, Bonnet M, Mazet R, Ego A, Pin I

Open source

DOI
10.1186/s12887-019-1804-0
Published
2019 Nov 8
Container
BMC pediatrics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12887-019-1804-0,
  title = {Nebulized hypertonic saline 3\% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial.},
  author = {Beal G and Barbier C and Thoret S and Rubio A and Bonnet M and Mazet R and Ego A and Pin I},
  year = {2019},
  journal = {BMC pediatrics},
  doi = {10.1186/s12887-019-1804-0},
  url = {https://doi.org/10.1186/s12887-019-1804-0}
}

RIS

TY  - JOUR
TI  - Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial.
AU  - Beal G
AU  - Barbier C
AU  - Thoret S
AU  - Rubio A
AU  - Bonnet M
AU  - Mazet R
AU  - Ego A
AU  - Pin I
PY  - 2019
JO  - BMC pediatrics
DO  - 10.1186/s12887-019-1804-0
UR  - https://doi.org/10.1186/s12887-019-1804-0
ER  - 

APA

G, B., C, B., S, T., A, R., M, B., R, M., A, E., & I, P. (2019). Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial.. BMC pediatrics. https://doi.org/10.1186/s12887-019-1804-0

Source records